Power Versus Temperature Controlled Ablation for Treatment of VT
A legfontosabb adatok
- Ki végzi
- University Hospitals Coventry and Warwickshire NHS Trust
- Hol
- Egyesült Királyság2 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 61 fő vett részt
- Kezdés
- 2022. szept. 26.
- Befejezés
- 2025. nov. 21.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Temperature controlled DiamondTemp (DT) ablation catheter
- Tacticath/Tactiflex (TF) ablation catheter
- A regiszteradat frissítve
- 2026. április 14.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- ≥ 18 years of age to give informed consent specific to national legal requirements
- Subject with 1 of the following:; Symptomatic VT (despite optimal medical therapy), 3 or more episodes of VT within 24 h (VT storm); At least 3 episodes of VT requiring anti-tachycardia pacing (ATP); At least one appropriate ICD shock
- Referred for VT ablation by Consultant Electrophysiologist
- Subject discussed at cardiac EP MDT
- Suitable candidate for intra-cardiac mapping and ablation of arrhythmia
- Subject agrees to comply with study procedures and be available for routine follow up visits for at least 12 months after enrolment
- Subject is willing and able to provide written consent
Ki nem vehet részt
- Sepsis, active systemic infection or fever (>100.5 F/38 C) within a week prior to the ablation procedure
- Known allergies or intolerance to anticoagulant and antiplatelet therapies to be used in conjunction with the study or contrast sensitivity that can't be adequately pre-treated prior to the ablation procedure
- Enrolment in a concurrent clinical study that in the judgement of the investigator would increase risk to the subject or deem the subject inappropriate to participate in the study
- Coagulopathy, bleeding diathesis or suspected pro-coagulant state
- Significant restrictive or obstructive pulmonary disease or chronic respiratory condition
- Renal failure requiring dialysis or renal compromise that in the investigators judgement would increase risk to the subject or deem the subject inappropriate to participate in the study
- BMI >40kg/m2
- Presence of intramural thrombus, tumour or abnormality that precludes vascular access, catheter introduction or manipulations
- Positive pregnancy test results for female subjects of childbearing or potential or breast feeding
- Significant GI bleed
Hol van ez a vizsgálat?
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Ventricular Tachycardia (VT) is a life threatening heart rhythm that comes from the bottom chambers of the heart (the ventricles) and is a leading cause of sudden cardiac death.
A teljes eredeti leírásKevesebb
The majority of patients that are at risk of VT or suffer a cardiac arrest will have an Internal Cardiac Defibrillator (ICD) in situ to treat the abnormal heart rhythm. The ICD can deliver a painful shock to restore normal heart rhythm but importantly does not treat the underlying cause. Current treatment for the prevention of recurrent VT include catheter ablation (CA) or medication. Long-term results with global 12 month VT-free survival rates with CA are around 50%.
The trial is to compare 2 different types of ablation catheter that are used to cauterise small areas of unhealthy tissue within the heart that are responsible for VT: Diamond Temp (DT) and Tacticath/Tactiflex (TF). Our hypothesis is that the DT ablation catheter will provide comparable efficacy and safety for the treatment of VT as the current industry gold standard (TF).
A vizsgálat 2 csoportja
- Temperature controlled DiamondTemp (DT) ablation catheterEgyéb csoport
Intervention arm
- Power controlled Tacticath/Tactiflex ablation catheterEgyéb csoport
Control arm
Kezelés: Tacticath/Tactiflex (TF) ablation catheter
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- A Randomised Control Trial of Power Versus Temperature-controlled Irrigated Radiofrequency Ablation for the Treatment of Ventricular Tachycardia (VT)
- A regiszteradat frissítve
- 2026. április 14.